cash per share approx 8.8 cents - small value given for research and development on current projects.
- Forums
- ASX - By Stock
- BLT
- Gene therapies take a hit
Gene therapies take a hit, page-16
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online